Financhill
Back

Olympus Quote, Financials, Valuation and Earnings

Olympus Price Quote

$15.14

Olympus Key Stats

Sell
24
Olympus (OLYMY) is a Sell

Day range:
$15.07 - $15.74
52-week range:
$13.13 - $19.69
Dividend yield:
0.76%
P/E ratio:
10.95
P/S ratio:
2.75
P/B ratio:
3.49%

Volume:
77.3K
Avg. volume:
95.5K
1-year change:
4.63%
Market cap:
$17.2B
Revenue:
$6.5B
EPS:
$0.23

How Much Does Olympus Make?

Data Unavailable

Is Olympus Growing As A Company?

Data Unavailable

Olympus Stock Price Performance

  • Did Olympus Stock Go Up Last Month?
    Olympus share price went down by -6.14% last month
  • Did OLYMY's Share Price Rise Over The Last Year?
    OLYMY share price rose by 4.63% over the past 1 year

What Is Olympus 52-Week High & Low?

  • What Is Olympus’s 52-Week High Share Price?
    Olympus has traded as high as $19.69 over the past 52 weeks
  • What Is Olympus’s 52-Week Low Share Price?
    Olympus has traded as low as $13.13 over the past 52 weeks

Olympus Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Olympus?

Data Unavailable

Is Olympus Cash Flow Positive?

Data Unavailable

Olympus Return On Invested Capital

Data Unavailable

Olympus Earnings Date & Stock Price

  • What Is Olympus's Stock Price Today?
    A single share of OLYMY can be purchased today for 15.14
  • What Is Olympus’s Stock Symbol?
    Olympus trades on the otcm under the ticker symbol: OLYMY
  • When Is Olympus’s Next Earnings Date?
    The next quarterly earnings date for Olympus is scheduled on February 14, 2025
  • When Is OLYMY's next ex-dividend date?
    Olympus's next ex-dividend date is March 27, 2024
  • How To Buy Olympus Stock?
    You can buy Olympus shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Olympus Competitors

  • Who Are Olympus's Competitors?
    Below is a list of companies who compete with Olympus or are related in some way:
    • AnGes Inc (AMGXF)
    • Healios KK (HLOSF)
    • PeptiDream Inc (PPTDF)
    • Nxera Pharma Co Ltd (SOLTF)
    • Takeda Pharmaceutical Co Ltd (TAK)

Olympus Dividend Yield

Data Unavailable

Olympus Analyst Estimates

YoY Growth Past Surprise
EPS: -85.64% 0%
Revenue: 6.38% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable